中东和非洲病毒学市场预测至 2028 年 - COVID-19 影响和按类型（诊断测试、病毒感染控制技术、抗病毒治疗和干扰素）、应用（皮肤和软组织感染、呼吸道感染、胃肠道感染）进行区域分析、性传播疾病、尿路感染等）和最终用户（医院、诊断实验室、制药和生物技术公司以及研究和学术机构）

市场介绍

中东和非洲病毒学市场包括阿联酋、沙特阿拉伯、南非和其他中东地区的综合市场东部和非洲。病毒爆发的增加、中东旅行者数量的增加正在推动病毒学市场的增长。此外，艾滋病毒和埃博拉等其他流行病在非洲的流行率不断上升，为病毒学市场创造了机会。此外，沙特阿拉伯是在 COVID-19 大流行期间可能因朝觐和副朝等入境旅行活动而受到严重影响的国家之一。预计到 2030 年，沙特阿拉伯将接待多达 3000 万名朝圣者，这会增加流行病的风险，并强调公共卫生当局需要采取新的应对疫情的方法，以防止任何上呼吸道病毒在这些时期传播。次。在发现 MERS-CoV 后，沙特卫生部 (MoH) 立即成立了沙特疾病控制和预防中心 (SCDC)，该中心现已投入运行，处于该国应对 COVID-19 的前线。此外，沙特卫生部还成立了国家卫生实验室（NHL），特别是通过高生物防护实验室为传染病提供先进的诊断。此外，沙特卫生部已指定超过25家地区医院用于隔离和治疗MERS患者。这些医院已做好充分准备来治疗 COVID-19 患者。此外，沙特阿拉伯也是世界卫生组织《国际卫生条例》的签署国之一，自世界卫生组织感染预防和控制政策以来一直在报告大流行的防范情况。因此，完善的医疗基础设施和结构完善的大流行病防范政策正在推动未来几年的病毒学市场。对高性价比产品的持续需求是推动 MEA 病毒学市场增长的主要因素。

经济的不确定性和持续的冲突正在加剧该地区的状况。例如，叙利亚、利比亚、也门等国家正遭受暴力冲突，无法实施任何公共卫生措施。由于美国的制裁，伊朗经济陷入严重衰退。此外，金融状况收紧也减少了该地区的经济活动。 COVID-19 是继 2012 年沙特阿拉伯报告中东呼吸综合征冠状病毒 (MERS-CoV) 后，影响中东的第二次冠状病毒爆发。该地区许多国家都面临检测试剂盒短缺的问题。考虑到这一点，许多政府组织纷纷出面帮助资源匮乏的国家。例如，9 月份，联合国儿童基金会 (UNICEF) 提供了约 115,800 个 Covid-19 检测套件，以帮助缓解尼日利亚的 Covid-19 大流行。此外，该地区国家正在与国际参与者合作，以提高测试能力。此外，埃博拉疫情对几内亚、利比里亚和塞拉利昂的健康和经济造成了巨大的直接影响，使基本医疗保健和政府服务转向疫情爆发，导致医疗和社会保健供应严重不足。由于疫情期间和爆发后金融投资和生产力水平下降，经济增长也显着放缓。根据全球基金组织的数据，在非洲 24 个国家中，只有 11% 的卫生机构可以进行 COVID-19 抗原快速诊断检测，只有 8% 的卫生机构可以进行 PCR 检测。在 COVID-19 之前，拉沙热是首要问题，西非每年约有 300,000-500,000 例拉沙热病例，其中 5,000 人死亡。然而，COVID-19 转移了应对这一流行病的所有注意力，阻碍了其他病毒感染的增长。

市场概况和动态

中东和非洲的病毒学市场预计将从 2021 年的 1.824 亿美元增长到 2028 年的 2.2146 亿美元；预计 2021 年至 2028 年复合年增长率为 2.8%。病毒学是医疗保健系统的重要部分之一。它在疫苗开发、诊断、治疗等方面有着广泛的应用。市场参与者不断参与产品创新和开发，以维持市场竞争。他们探索产品创新的各个领域。例如，对于 COVID-19，市场参与者正在大力投资疫苗、检测试剂盒以及其他相关产品和服务的开发。以下是与病毒学市场相关的一些市场动态：

• 2021 年 8 月，美国食品和药物管理局 (FDA) 批准了第一种 COVID-19 疫苗，称为辉瑞 BioNTech COVID-19 疫苗。它将作为 ComiRNAty (Koe-mir’-na-tee) 上市。该疫苗旨在预防 16 岁及以上个体的 COVID-19 疾病。也可在紧急使用授权 (EUA) 下使用。

• 2021 年 4 月，CerTest Biotec 为 BD MAX 系统推出了具有 CE 标志的 COVID-19 诊断测试。

• ; 2020 年 5 月，Bio-Rad 获得 FDA 批准，可以紧急使用 COVID-19 总抗体检测授权。

• 2020 年 5 月，Aalto Bio Reagents 推出了新型重组真核 SARS-CoV-2 S1-S2 刺突蛋白。

因此，市场参与者通过产品创新和有利的政府支持的积极参与预计将增强MEA 病毒学市场的增长。

关键市场细分

MEA 病毒学市场根据类型、应用程序、最终用户和国家/地区。根据类型，市场分为诊断测试、病毒感染控制技术、抗病毒治疗和干扰素。抗病毒治疗领域在 2020 年占据市场主导地位，病毒感染控制技术领域预计将在预测期内增长最快。诊断测试部分进一步分为DNA病毒测试、RNA病毒测试等。同样，病毒感染控制技术分为主动预防和被动预防。同样，抗病毒治疗分为杀病毒剂、抗病毒剂、免疫调节剂和干扰素。根据应用，病毒学市场分为皮肤和软组织感染、呼吸道感染、胃肠道感染、性传播疾病、尿路感染等。呼吸道感染领域在 2020 年占据市场主导地位，预计将在预测期内增长最快。根据最终用户，病毒学市场分为医院、诊断实验室、制药和生物技术公司以及研究和学术机构。医院细分市场在 2020 年占据市场主导地位，诊断实验室细分市场预计将在预测期内增长最快。

主要来源和上市公司

准备本中东和非洲病毒学市场报告时提到的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有雅培（Abbott）；艾伯维公司； F.霍夫曼-拉罗氏有限公司；吉利德科学公司；葛兰素史克公司；照明公司；强生服务公司；凯杰；西门子公司；和 Thermo Fisher Scientific Inc. 等。

购买报告的理由

了解 MEA 病毒学市场格局，并确定最有可能保证强劲回报的细分市场
通过理解来保持竞争优势MEA 病毒学市场不断变化的竞争格局
通过识别最有可能销售前景的细分市场，有效规划 MEA 病毒学市场的并购和合作交易
帮助通过对 MEA 病毒学市场各个细分市场的市场表现进行敏锐和全面的分析，做出明智的业务决策
获取 MEA 地区各个细分市场 2021-2028 年的市场收入预测。

MEA 病毒学市场细分

MEA 病毒学市场 - 按类型

诊断检测
- DNA病毒检测
- RNA病毒检测
- 其他
病毒感染控制技术
- 主动预防
- 被动预防
抗病毒治疗
- 杀病毒剂
- 抗病毒剂
- 免疫调节剂
干扰素

MEA病毒学市场 - 按应用

MEA 病毒学市场 - 按最终用户

医院
诊断实验室
制药和生物技术公司
研究和学术机构

MEA 病毒学市场 - 按国家/地区

阿联酋
沙特阿拉伯
南非
中东和非洲其他地区

< p>MEA 病毒学市场 -公司简介
Abbott
艾伯维公司
F. Hoffmann-La Roche Ltd.
吉利德科学公司
葛兰素史克公司
Illumina, Inc.
强生服务公司， Inc.
QIAGEN
西门子股份公司
Thermo Fisher Scientific Inc.

TABLE OF CONTENTS
1.           Introduction
1.1         Scope of the Study
1.2         The Insight Partners Research Report Guidance
1.3         Market Segmentation
1.3.1        MEA Virology Market – By Type
1.3.2        MEA Virology Market – By Application
1.3.3        MEA Virology Market – By End User
1.3.4        MEA Virology Market– By Country
2.           MEA Virology Market – Key Takeaways
3.           Research Methodology
3.1         Coverage
3.2         Secondary Research
3.3         Primary Research
4.           MEA Virology Market– Market Landscape
4.1         Overview
4.2         MEA PEST Analysis
4.3         Experts Opinion
5.           MEA Virology Market – Key Market Dynamics
5.1         Market Drivers
5.1.1        Increasing Prevalence of Viral Infectious Diseases
5.1.2        Increasing Product Launches
5.2         Market Restraints
5.2.1        Availability of Alternative Products and High Price of Production of Products
5.3         Market Opportunities
5.3.1        Major Growth Potential in Emerging Economies
5.4         Future Trends
5.4.1        Continuous Requirement for Cost-Effective Products
5.5         Impact Analysis
6.           Virology Market– MEA Analysis
6.1         MEA Virology Market Revenue Forecast and Analysis
7.           MEA Virology Market Analysis – By Type
7.1         Overview
7.2         MEA Virology Market Revenue Share, by Type (2021 and 2028)
7.3         Diagnostic Test
7.3.1        Overview
7.3.2        Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.1          Deoxyribonucleic Acid (DNA) Virus Testing
7.3.2.1.1          Overview
7.3.2.1.2          DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.2          Ribonucleic Acid (RNA) Virus Testing
7.3.2.2.1          Overview
7.3.2.2.2          RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.3          Others
7.3.2.3.1          Overview
7.3.2.3.2          Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4         Viral Infection Controlling Techniques
7.4.1        Overview
7.4.2        Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.1          Active Prophylaxis
7.4.2.1.1          Overview
7.4.2.1.2          Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.2          Passive Prophylaxis
7.4.2.2.1          Overview
7.4.2.2.2          Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5         Antiviral Therapeutics
7.5.1        Overview
7.5.2        Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.1          Virucidal Agents
7.5.2.1.1          Overview
7.5.2.1.2          Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.2          Antiviral Agents
7.5.2.2.1          Overview
7.5.2.2.2          Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.3          Immunomodulators
7.5.2.3.1          Overview
7.5.2.3.2          Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.6         Interferons
7.6.1        Overview
7.6.2        Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.           MEA Virology Market Analysis – By Application
8.1         Overview
8.2         MEA Virology Market, by Application 2021 & 2028 (%)
8.3         Skin and Soft Tissue Infections
8.3.1        Overview
8.3.2        Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.4         Respiratory Tract Infections
8.4.1        Overview
8.4.2        Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.5         GI Tract Infections
8.5.1        Overview
8.5.2        GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.6         Sexually Transmitted Diseases
8.6.1        Overview
8.6.2        Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.7         Urinary Tract Infections
8.7.1        Overview
8.7.2        Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.8         Others
8.8.1        Overview
8.8.2        Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.           MEA Virology Market Analysis – By End User
9.1         Overview
9.2         MEA Virology Market Revenue Share, by End User (2021 and 2028)
9.3         Hospitals
9.3.1        Overview
9.3.2        Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.4         Diagnostic Laboratories
9.4.1        Overview
9.4.2        Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.5         Pharmaceutical and Biotechnological Companies
9.5.1        Overview
9.5.2        Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.6         Research and Academic Institutes
9.6.1        Overview
9.6.2        Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)
10.        MEA Virology Market – Country Analysis
10.1.1     Overview
10.1.2     Middle East & Africa: Virology Market, by Country, 2021 & 2028 (%)
10.1.2.1       Saudi Arabia: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1       Saudi Arabia: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2       Saudi Arabia Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2.1    Saudi Arabia: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.1.2.2    Saudi Arabia: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.1.2.3    Saudi Arabia: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.1.3       Saudi Arabia: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.4       Saudi Arabia: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.2       UAE: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1       UAE: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2       UAE Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2.1    UAE: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.2.2.2    UAE: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.2.2.3    UAE: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.2.3       UAE: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.4       UAE: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.3       South Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1       South Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2       South Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2.1    South Africa: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.3.2.2    South Africa: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.3.2.3    South Africa: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.3.3       South Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4       South Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.4       Rest of Middle East and Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.1       Rest of Middle East and Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.2       Rest of Middle East and Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.2.1    Rest of Middle East and Africa: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.4.2.2    Rest of Middle East and Africa: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.4.2.3    Rest of Middle East and Africa: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.4.3       Rest of Middle East and Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.4       Rest of Middle East and Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.        Impact of COVID-19 Pandemic on MEA Virology Market
11.1      Overview
12.        MEA Virology Market–Industry Landscape
12.1      Overview
12.2      Organic Developments
12.2.1     Overview
12.3      Inorganic Developments
12.3.1     Overview
13.        Company Profiles
13.1      Abbott
13.1.1     Key Facts
13.1.2     Business Description
13.1.3     Products and Services
13.1.4     Financial Overview
13.1.5     SWOT Analysis
13.1.6     Key Developments
13.2      Johnson and Johnson Services, Inc.
13.2.1     Key Facts
13.2.2     Business Description
13.2.3     Products and Services
13.2.4     Financial Overview
13.2.5     SWOT Analysis
13.2.6     Key Developments
13.3      F. HOFFMANN-LA ROCHE LTD.
13.3.1     Key Facts
13.3.2     Business Description
13.3.3     Products and Services
13.3.4     Financial Overview
13.3.5     SWOT Analysis
13.3.6     Key Developments
13.4      THERMO FISHER SCIENTIFIC INC.
13.4.1     Key Facts
13.4.2     Business Description
13.4.3     Products and Services
13.4.4     Financial Overview
13.4.5     SWOT Analysis
13.4.6     Key Developments
13.5      QIAGEN
13.5.1     Key Facts
13.5.2     Business Description
13.5.3     Products and Services
13.5.4     Financial Overview
13.5.5     SWOT Analysis
13.5.6     Key Developments
13.6      Illumina, Inc.
13.6.1     Key Facts
13.6.2     Business Description
13.6.3     Products and Services
13.6.4     Financial Overview
13.6.5     SWOT Analysis
13.6.6     Key Developments
13.7      Siemens AG
13.7.1     Key Facts
13.7.2     Business Description
13.7.3     Products and Services
13.7.4     Financial Overview
13.7.5     SWOT Analysis
13.7.6     Key Developments
13.8      GlaxoSmithKline Plc
13.8.1     Key Facts
13.8.2     Business Description
13.8.3     Products and Services
13.8.4     Financial Overview
13.8.5     SWOT Analysis
13.8.6     Key Developments
13.9      AbbVie Inc.
13.9.1     Key Facts
13.9.2     Business Description
13.9.3     Products and Services
13.9.4     Financial Overview
13.9.5     SWOT Analysis
13.9.6     Key Developments
13.10   Gilead Sciences, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14.        Appendix
14.1      About The Insight Partners
14.2      Glossary of Terms

LIST OF TABLES
Table 1.             MEA Virology Market Revenue and Forecast to 2028 (US$ Million)
Table 2.             Saudi Arabia Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 3.             Saudi Arabia Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 4.             Saudi Arabia Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 5.             Saudi Arabia Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 6.             Saudi Arabia: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7.             Saudi Arabia: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 8.             UAE Virology Market, By Type – Revenue and Forecast to 2028(USD Million)
Table 9.             UAE Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 10.          UAE Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 11.          UAE Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 12.          UAE: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13.          UAE: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 14.          South Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 15.          South Africa Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 16.          South Africa Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 17.          South Africa Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 18.          South Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 19.          South Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 20.          Rest of Middle East and Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 21.          Rest of Middle East and Africa Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 22.          Rest of Middle East and Africa Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 23.          Rest of Middle East and Africa Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 24.          Rest of Middle East and Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 25.          Rest of Middle East and Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 26.          Organic Developments Done by Companies
Table 27.          Inorganic Developments Done by Companies
Table 28.          Glossary of Terms, Virology Market

LIST OF FIGURES
Figure 1.           MEA Virology Market Segmentation
Figure 2.           MEA Virology Segmentation, By Country
Figure 3.           MEA Virology Market Overview
Figure 4.           Antiviral Therapeutics Held the Largest Share of the Type Segment in MEA Virology Market
Figure 5.           Respiratory Tract Infections Held the Largest Share of the Application Segment in MEA Virology Market
Figure 6.           South Africa to Show Significant Growth During Forecast Period
Figure 7.           MEA PEST Analysis
Figure 8.           MEA Virology Market: Impact Analysis of Drivers and Restraints
Figure 9.           MEA Virology Market– Revenue Forecast and Analysis – 2019- 2028
Figure 10.        MEA Virology Market Revenue Share, by Type (2021 and 2028)
Figure 11.        MEA Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12.        MEA DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13.        MEA RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14.        MEA Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15.        MEA Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16.        MEA Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17.        MEA Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18.        MEA Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19.        MEA Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20.        MEA Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21.        MEA Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22.        MEA Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23.        MEA Virology Market, by Application 2021 & 2028 (%)
Figure 24.        MEA Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25.        MEA Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26.        MEA GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27.        MEA Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28.        MEA Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29.        MEA Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30.        MEA Virology Market Revenue Share, by End User (2021 and 2028)
Figure 31.        Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32.        Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33.        Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34.        Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35.        Middle East and Africa: Virology Market, by Key Country – Revenue (2021) (USD Million)
Figure 36.        Middle East & Africa: Virology Treatment Market, by Country, 2021 & 2028 (%)
Figure 37.        Saudi Arabia: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 38.        UAE: Virology Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 39.        South Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 40.        Rest of Middle East and Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 41.        Impact of COVID-19 Pandemic on Virology Market in MEA Countries

Abbott
AbbVie Inc.
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Illumina, Inc.
Johnson and Johnson Services, Inc.
QIAGEN
Siemens AG
Thermo Fisher Scientific Inc.

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the MEA Virology market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the MEA Virology market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the Virology market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code

Full Name

Country Name

Email Id

Phone Number

Job Title

Company

Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name Published Date

Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S.. May 2022

Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En.. May 2022

Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M.. May 2022

Report Name	Published Date
Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S..	May 2022
Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En..	May 2022
Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount

Subscription Member Price: FREE
Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.